Henry Schein, Inc. (Nasdaq: HSIC) has entered into a new exclusive distribution agreement with CytoChip Inc. for its flagship product, the CitoCBC® system, a U.S. Food and Drug Administration (FDA) ...
Proteomics International Laboratories has named medtech veteran David Morris as CEO and managing director to drive the ...
Lotus Endometriosis Institute releases important update on microRNA research for potential non-invasive blood test to ...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing and precision medicine, today announced an ...
Fulgent Genetics agrees to buy StrataDx and assets from Bako Diagnostics for $55.5 million. Learn how this cash deal expands ...
BURTON, MI, UNITED STATES, January 9, 2026 /EINPresswire.com/ -- Javelin Sciences, a pioneering certified biotechnology ...
Helio Genomics announced a partnership with Ohio-based LiverRight Inc. to integrate its new early liver cancer detection test ...
KNOXVILLE, TN, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- Daisy Genomics Inc. (“Daisy Genomics”) and New Day ...
CyPath® Lung addresses urgent unmet need in projected $10.4 billion lung cancer diagnostic market by 2034Precision Pathology Laboratory Services meets gold standard for excellence across all ...
BURTON, MI, UNITED STATES, January 9, 2026 /EINPresswire.com/ -- Javelin Sciences, a CLIA-certified biotechnology ...
Artificial intelligence is making its way into every aspect of life, including cancer prevention. New technology at MUSC is ...
StockStory.org on MSN
Guardant Health (NASDAQ:GH): Strongest Q3 results from the testing & diagnostics services group
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results